Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Takeda in Talks with Shire after 3 Buyout Proposals Rejected
April 20, 2018
- Toho Grabs 8% Stake in NKT Cell Immunotherapy Startup
April 19, 2018
- Astellas Sells Agensys Research Facilities to Kite
April 19, 2018
- US Appeals Court Favors Sumitomo Dainippon in Latuda Substance Patent Suit
April 19, 2018
- FDA Clears Kyowa Kirin/Ultragenyx’s XLH Drug Burosumab
April 19, 2018
- Tecentriq Now in PD-1/L1 NSCLC Showdown, Lynparza Also Hits Japan Market
April 19, 2018
- PeptiStar’s Funding Procurement Nears 20 Billion Yen
April 19, 2018
- Former GSK Japan Chief Kanako Kikuchi Named UCB Japan President
April 19, 2018
- Pharmbio Korea Gets Rights to Shionogi’s Ospemifene
April 18, 2018
- Another Huge Seller Re-Pricing Won’t Hit Opdivo Unless 195 Billion Yen Sales Reached: Ono Chief
April 18, 2018
- Sumitomo Dainippon Reorganizes Drug Discovery Research System; Accelerating Decision-Making: Pres.
April 18, 2018
- ASKA to Set Up Plant in India under JV, Eying Operation Launch in 2020
April 18, 2018
- Novo Japan Renews Sales Record in 2017 as Tresiba, Ryzodeg Gain Ground
April 17, 2018
- AstraZeneca Aims to Join Top League in Japan as It Plans Record 7 Launches in 2018
April 17, 2018
- Tagrisso Selected for 23.7% of Japanese NSCLC Patients Whose Cancer Progressed on EGFR-TKIs: Observational Study
April 17, 2018
- Eisai Teams Up with US Academia to Develop Novel TB Drugs
April 17, 2018
- Taisho Files Taurine for Recurrence Prevention of Stroke-Like Episodes in MELAS in Japan
April 17, 2018
- Tecentriq to Provide New Option for NSCLC: Oncologists
April 16, 2018
- Asian Regenerative Medicine Associations Held 1st Symposium on Regulatory Harmonization in Tokyo
April 16, 2018
- Takeda CEO Eager to Lure More Partners to Shonan iPark, Says Diversity Is Source of Creativity
April 16, 2018
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…